Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

DTP's Office of the Associate Director

DTP provides resources and services to both public and private research communities. It maintains a robust infrastructure for anti-cancer drug discovery and development and manages a large portfolio of grants pertinent to drug discovery, biochemical pharmacology, immuno-oncology, and biopharmaceutical discovery and development. Upon request, DTP also provides advice on drug development issues regarding the regulatory critical path for preclinical development including chemistry, manufacturing & control, pharmacology & toxicology, and IND requirements.

DTP/OAD provides planning, implementation, coordination and oversight for all DTP activities.

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “DTP's Office of the Associate Director was originally published by the National Cancer Institute.”

Email